{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:48:42Z","timestamp":1791139722356,"version":"4.1.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2020.00058","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:47:57Z","timestamp":1585921677000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Advantages and Recent Developments of Autologous Cell Therapy for Parkinson\u2019s Disease Patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Teresia M.","family":"Osborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope J.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E5","article-title":"Recent advances in cell-based therapy for Parkinson disease.","volume":"24","author":"Astradsson","year":"2008","journal-title":"Neurosurg. Focus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/s1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease.","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.","volume":"99","author":"Bjorklund","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology.","volume":"89","author":"Borovac","year":"2016","journal-title":"Yale J. Biol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/mdc3.12819","article-title":"The evolution of quality of life after subthalamic stimulation for parkinson\u2019s disease: a meta-analysis.","volume":"6","author":"Buttner","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1634\/stemcells.2008-0734","article-title":"The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson\u2019s disease model.","volume":"27","author":"Cai","year":"2009","journal-title":"Stem Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/1801200a0","article-title":"3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00419","article-title":"A review of cognitive outcomes across movement disorder patients undergoing deep brain stimulation.","volume":"10","author":"Cernera","year":"2019","journal-title":"Front. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1634\/stemcells.2008-0085","article-title":"Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats.","volume":"26","author":"Chiba","year":"2008","journal-title":"Stem Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/bf00279666","article-title":"Human fetal dopamine neurons grafted in a rat model of Parkinson\u2019s disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry.","volume":"73","author":"Clarke","year":"1988","journal-title":"Exp. Brain Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00415-009-5242-z","article-title":"Lack of functional relevance of isolated cell damage in transplants of Parkinson\u2019s disease patients.","volume":"256","author":"Cooper","year":"2009","journal-title":"J. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.mcn.2010.06.017","article-title":"Differentiation of human ES and Parkinson\u2019s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.","volume":"45","author":"Cooper","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/b978-0-444-59575-1.00012-0","article-title":"Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.","volume":"200","author":"Cooper","year":"2012","journal-title":"Prog. Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2014.10.006","article-title":"hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice.","volume":"15","author":"Cunningham","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/mdc3.12780","article-title":"Cost-effectiveness of deep brain stimulation with movement disorders: a systematic review.","volume":"6","author":"Dang","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/exnr.1997.6674","article-title":"Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation.","volume":"149","author":"Deacon","year":"1998","journal-title":"Exp. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nm0397-350","article-title":"Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson\u2019s disease.","volume":"130","author":"Deacon","year":"1997","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0963-6897(95)02040-3","article-title":"Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation.","volume":"5","author":"Dinsmore","year":"1996","journal-title":"Cell Transpl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","article-title":"Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.","volume":"2","author":"Doi","year":"2014","journal-title":"Stem Cell Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2013.02.016","article-title":"Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.","volume":"3","author":"Emborg","year":"2013","journal-title":"Cell Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","article-title":"The threshold theory for Parkinson\u2019s disease.","volume":"40","author":"Engelender","year":"2017","journal-title":"Trends Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/bf01250010","article-title":"\u201cOn-off\u201d phenomenon in Parkinson\u2019s disease: correlation to the concentration of dopa in plasma.","volume":"59","author":"Eriksson","year":"1984","journal-title":"J Neural Transm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson\u2019s disease as a clinical syndrome.","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/brcg.1999.1104","article-title":"Cognitive outcomes after deep brain stimulation for Parkinson\u2019s disease: a review of initial studies and recommendations for future research.","volume":"42","author":"Fields","year":"2000","journal-title":"Brain Cogn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/096368970000900212","article-title":"Porcine xenografts in Parkinson\u2019s disease and Huntington\u2019s disease patients: preliminary results.","volume":"9","author":"Fink","year":"2000","journal-title":"Cell Transpl."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson\u2019s disease.","volume":"327","author":"Freed","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington\u2019s disease: phenotypic development and lack of pathology.","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/science.1218071","article-title":"Glial progenitor cell-based treatment and modeling of neurological disease.","volume":"338","author":"Goldman","year":"2012","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease.","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8257(200003)15:2<224::aid-mds1004>3.0.co;2-w","article-title":"Health-related quality of life following bilateral intrastriatal transplantation in Parkinson\u2019s disease.","volume":"15","author":"Hagell","year":"2000","journal-title":"Mov. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","article-title":"Long-term health of dopaminergic neuron transplants in Parkinson\u2019s disease patients.","volume":"7","author":"Hallett","year":"2014","journal-title":"Cell Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease.","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"15921","DOI":"10.1073\/pnas.1010209107","article-title":"Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats.","volume":"107","author":"Hargus","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1634\/stemcells.2007-0996","article-title":"Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson\u2019s disease.","volume":"26","author":"Hedlund","year":"2008","journal-title":"Stem Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1152\/jn.00281.2015","article-title":"Mechanisms of deep brain stimulation.","volume":"115","author":"Herrington","year":"2016","journal-title":"J. Neurophysiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1002\/ana.10482","article-title":"Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson\u2019s disease by stem cells.","volume":"53","author":"Isacson","year":"2003","journal-title":"Ann. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1002\/ana.21473","article-title":"Future of cell and gene therapies for Parkinson\u2019s disease.","volume":"64","author":"Isacson","year":"2008","journal-title":"Ann. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.stem.2016.10.003","article-title":"Single-cell analysis reveals a close relationship between differentiating dopamine and subthalamic nucleus neuronal lineages.","volume":"20","author":"Kee","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term clinical outcome of fetal cell transplantation for parkinson disease: two case reports.","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-neuro-070918-050443","article-title":"The emerging nature of astrocyte diversity.","volume":"42","author":"Khakh","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model.","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.stem.2016.09.004","article-title":"Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson\u2019s disease.","volume":"20","author":"Kirkeby","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/mds.870130303","article-title":"Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson\u2019s disease.","volume":"13","author":"Kordower","year":"1998","journal-title":"Mov. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0963-6897(97)00019-5","article-title":"Fetal grafting for Parkinson\u2019s disease: expression of immune markers in two patients with functional fetal nigral implants.","volume":"6","author":"Kordower","year":"1997","journal-title":"Cell Transpl."},{"key":"B45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease.","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease.","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/jpd-2011-11004","article-title":"Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson\u2019s disease.","volume":"1","author":"Kurowska","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection.","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation.","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson\u2019s disease.","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/s0140-6736(88)90950-6","article-title":"Fetal dopamine-rich mesencephalic grafts in Parkinson\u2019s disease.","volume":"2","author":"Lindvall","year":"1988","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/bmt.2012.133","article-title":"Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database.","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transpl."},{"key":"B54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2007.08.008","article-title":"Viral vectors for in vivo gene transfer in Parkinson\u2019s disease: properties and clinical grade production.","volume":"209","author":"Mandel","year":"2008","journal-title":"Exp. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/exnr.1999.7159","article-title":"Progress in direct striatal delivery of L-dopa via gene therapy for treatment of Parkinson\u2019s disease using recombinant adeno-associated viral vectors.","volume":"159","author":"Mandel","year":"1999","journal-title":"Exp. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","article-title":"Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease.","author":"Mendez","year":"2005","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nm1752","article-title":"Dopamine neurons implanted into people with Parkinson\u2019s disease survive without pathology for 14 years.","volume":"14","author":"Mendez","year":"2008","journal-title":"Nat. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1525-1403.2012.00457.x","article-title":"An algorithm for management of deep brain stimulation battery replacements: devising a web-based battery estimator and clinical symptom approach.","volume":"16","author":"Montuno","year":"2013","journal-title":"Neuromodulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate.","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"key":"B60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates.","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat. Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0896-6273(01)80028-3","article-title":"Convergent inductive signals specify midbrain, hindbrain, and spinal cord identity in gastrula stage chick embryos.","volume":"23","author":"Muhr","year":"1999","journal-title":"Neuron"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/nprot.2017.078","article-title":"Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.","volume":"12","author":"Nolbrant","year":"2017","journal-title":"Nat. Protoc."},{"key":"B63","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nn0602-854","article-title":"Progressive induction of caudal neural character by graded Wnt signaling.","volume":"5","author":"Nordstrom","year":"2002","journal-title":"Nat. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0040252","article-title":"An early role for WNT signaling in specifying neural patterns of Cdx and Hox gene expression and motor neuron subtype identity.","volume":"4","author":"Nordstrom","year":"2006","journal-title":"PLoS Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease.","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"B66","article-title":"Pre-clinical studies toward autologous midbrain dopamine cell therapy for Parkinson\u2019s disease.","author":"Osborn","year":"2020","journal-title":"StemJournal"},{"key":"B67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2016.12.014","article-title":"Seq-ing markers of midbrain dopamine neurons.","volume":"20","author":"Osborn","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B68","author":"Osborn","year":"2017","journal-title":"Preclinical Characterization of Frozen-Thawed Dopaminergic Cell Preparations for Parkinson\u2019s Disease Autologous Cell Replacement Therapy."},{"key":"B69","article-title":"Pre-clinical in vitro and in vivo characterization of xeno-free and foot-print-free iPSC-derived cell preparations for Parkinson\u2019s disease cell therapy.","author":"Osborn","year":"2015","journal-title":"Soc. Neurosci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41583-019-0257-7","article-title":"The future of stem cell therapies for Parkinson disease.","volume":"21","author":"Parmar","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson\u2019s patient.","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000976","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants.","volume":"2","author":"Politis","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B73","first-page":"701","article-title":"Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson\u2019s disease.","volume":"57","author":"Radad","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nbd.2007.08.008","article-title":"Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson\u2019s disease.","volume":"29","author":"Redmond","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nbt.3835","article-title":"Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson\u2019s disease model.","volume":"35","author":"Rivetti di Val Cervo","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-120-2-199401150-00008","article-title":"Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG).","volume":"120","author":"Rowe","year":"1994","journal-title":"Ann. Int. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nm1495","article-title":"Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.","volume":"12","author":"Roy","year":"2006","journal-title":"Nat. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0006-8993(81)91313-5","article-title":"Intracerebral grafting of dissociated CNS tissue suspensions: a new approach for neuronal transplantation to deep brain sites.","volume":"218","author":"Schmidt","year":"1981","journal-title":"Brain Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/wnl.54.5.1042","article-title":"Transplantation of embryonic porcine mesencephalic tissue in patients with Parkinson\u2019s disease.","volume":"54","author":"Schumacher","year":"2000","journal-title":"Neurology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.06.018","article-title":"The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.","volume":"32","author":"Soderstrom","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1634\/stemcells.2006-0380","article-title":"Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.","volume":"25","author":"Sonntag","year":"2007","journal-title":"Stem Cells"},{"key":"B82","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0306-4522(87)90207-7","article-title":"Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.","volume":"22","author":"Strecker","year":"1987","journal-title":"Neuroscience"},{"key":"B83","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/bs.pbr.2017.02.008","article-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.","volume":"230","author":"Studer","year":"2017","journal-title":"Prog. Brain Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/stem.1415","article-title":"Improved cell therapy protocols for Parkinson\u2019s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.","volume":"31","author":"Sundberg","year":"2013","journal-title":"Stem Cells"},{"key":"B85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/bs.pbr.2016.11.004","article-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic: the Kyoto trial.","volume":"230","author":"Takahashi","year":"2017","journal-title":"Prog. Brain Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors.","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00415-011-6061-6","article-title":"Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson\u2019s disease.","volume":"258","author":"Tsui","year":"2011","journal-title":"J. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1093\/brain\/awn192","article-title":"Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson\u2019s disease.","author":"Vinuela","year":"2008","journal-title":"Brain"},{"key":"B89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stemcr.2017.04.033","article-title":"Cryopreservation maintains functionality of human iPSC dopamine neurons and rescues parkinsonian phenotypes in vivo.","volume":"9","author":"Wakeman","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson\u2019s disease.","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","volume":"327","author":"Widner","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1634\/stemcells.2007-0494","article-title":"Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats.","volume":"26","author":"Yang","year":"2008","journal-title":"Stem Cells"},{"key":"B93","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/0006-8993(86)90460-9","article-title":"In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.","volume":"362","author":"Zetterstrom","year":"1986","journal-title":"Brain Res."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2020.00058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:48:00Z","timestamp":1585921680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2020.00058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":93,"alternative-id":["10.3389\/fncel.2020.00058"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2020.00058","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"article-number":"58"}}